CDSCO monthly lab alert
CDSCO NSQ alert, June 2026: 193 drug batches flagged
By Blacklisted editorial team· Published 20 Jul 2026· Updated 3 Nov 2026· Source: CDSCO NSQ portal
In its June 2026 alert, the Central Drugs Standard Control Organisation listed 193 drug batches that failed quality tests, 27 at central laboratories and 166 at state drug-testing laboratories, from 145 manufacturers across 123 products. The most common failure was other, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Amoxycillin Oral Suspension IP, Gamma Benzene Hexachloride Lotion USP, Paracetamol Tablets IP 500 mg.
193
Batches flagged
27 / 166
Central / state labs
Other
Top reason
145
Manufacturers
Batches per month, last 12 alerts
Jul 2025Jun 2026 · 193
Full list of NSQ batches, June 2026
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| Voglibose Tablets I.P 0.3mg | Batch VBT1408Mfg Apr 2026 · Exp Mar 2028 | Unicure India Ltd | MisbrandedMisbranded | Andmand NicobarState lab |
| Vitamin B1 Vitamin B6 Vitamin B2 Niacinamide Calcium D Pentothenate | Batch 10512Mfg Feb 2025 · Exp Jan 2027 | Healthy Life Pharma Pvt. LtdMaharashtra | Vitamin B1 & for reason stated under descriptionDescription | SDT&RL, BhubaneswarState lab |
| Vitamin B- Complex Forte Zinc Capsules. | Batch CV-1120052Mfg Nov 2024 · Exp Oct 2026 | Centurion Remedies Pvt. LtdGujarat | Sample fails in the descriptive part as per schedule V of drugs and cosmetics act and rules there under.Other | RDTL, ErnakulamState lab |
| Trypsin-Chymotrypsin Tablets | Batch 2KU6M021Mfg May 2025 · Exp Apr 2028 | Torrent Pharmaceuticals LtdSikkim | The sample does not conform to Manufacturer's specification with respect to Assay of Trypsin-Chymotrypsin activity.Assay | CDL KolkataCDSCO lab |
| Triphala Churna | Batch TRC0924Mfg Sep 2024 · Exp Aug 2026 | Inducare Pharma Pvt. Ltd.Factory-C-34Maharashtra | Light brown coloured powder containing lumps 2. The sample does not found to contain insects, wabbing, Larvae and any other extraneous matter when observed in normal day light with naked eye.Description | FDAL, MumbaiState lab |
| Tolperisone Hydrochloride 150 mg and Diclofenac Sodium 50 mg | Batch WON24021GMfg Nov 2024 · Exp Oct 2026 | Windlas Biotech Limited (Plant-2)Uttarakhand | ContentOther | DTL, Madurai-19State lab |
| Tinycold-AF Chlorpheniramine Maleate & Phenylephrine Hydrochloride Syrup IP | Batch AI.25089Mfg Jul 2025 · Exp Jun 2027 | Cian Healthcare Ltd. Kh.No. 248Uttarakhand | The content of phanylephrine Hydrochloride in the sample is less (i.e. 66.80% of the labelled amount) than IP limit (IP 90% to 110%)Labelling | FDAL, MumbaiState lab |
| Thiocolchicoside Injection 4mg/2ml | Batch UFI60301Mfg Mar 2026 · Exp Feb 2028 | VTV Formulations India Pvt.Ltd.AtHimachal Pradesh | The sample does not confirm to the prescribed Standards of quality with respect to following three parameters Decription,Particulate matter,Sterility Test.Sterility | DTL,DALGATE SRINAGAR KASHMIR( J AND K)State lab |
| Thiamine Riboflavin, Niacinamide, Cynocobalamin & Liver Crude Injection (LIVGROW) Vetrinary Injection. | Batch VL250515Mfg Feb 2026 · Exp Jan 2028 | VADSP PharmaceuticalsHimachal Pradesh | The sample does not conform to the claim with respect to Assay of Cynocobalamin (Nil) and Riboflavin (Nil)Assay | DTL JaipurState lab |
| Terbutaline Sulphate, Bromhexine Hydrochloride, Guaiphenesin & Menthol Syrup | Batch EM1LF005Mfg Apr 2025 · Exp Mar 2027 | Unicure India LtdUttarakhand | ContentOther | DTL, Chennai-06State lab |
| Terbutaline Sulphate, Bromhexine HCl, Guaiphenesin & Menthol Syrup | Batch M24317Mfg Dec 2024 · Exp Nov 2026 | Healcure LifesciencesHimachal Pradesh | Assay for Bromhexine Hydrochloride and Description as per Schedule V of Drugs and Cosmetics Act 1940 & Rules 1945 thereunderAssay | DTL, Bengaluru, KarnatakaState lab |
| Terbutaline Sulphate, Ambroxol Hydrochloride, Guaiphenesin & Menthol Expectorant | Batch JLI2586Mfg Sep 2025 · Exp Aug 2027 | Janveda Healthceutical Pvt. LtdGujarat | Ambroxol Hydrochloride contentOther | FDL, VadodaraState lab |
| Telmisartan Tablets IP 80mg | Batch PT50022AMfg Nov 2025 · Exp Oct 2027 | Gnosis Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab |
| Telmisartan Tablets IP 40mg | Batch GTM94Mfg May 2025 · Exp Apr 2027 | Super Formulations Pvt. Ltd | DissolutionDissolution | DTL, Chennai-06State lab |
| Telmisartan Tablets IP 40mg | Batch MT-032673Mfg Mar 2026 · Exp Feb 2028 | Merion Care Pvt.LtdHimachal Pradesh | Dissolution and ContentDissolution | DTL, Chennai-06State lab |
| Telmisartan Tablets IP 40mg | Batch RT-251154Mfg Nov 2025 · Exp Oct 2027 | Relief Biotech Pvt. LtdDelhi | 1. Description 2. Dissolution (7Units Foumd to be less than 60% against I.P Limit of max. Two Units to be less than 60% against labeled claim also 7units found to be less than 50% against I.P Limit of No Unit to be less than 50% against Labeled claim.)Dissolution | SDTL, PunjabState lab |
| Telmisartan Tablets IP 40 mg | Batch TM5143Mfg Sep 2025 · Exp Aug 2027 | Kerala State Drugs and Pharmaceuticals LtdKerala | It fails the Descriptive part for tablets as per IP, as specified in the laboratory protocol. As per IP, tablets should have sufficient hardness to withstand handling without crumbling or breaking. These tablets are soft and in powdered condition and cannot be removed from the strips in intact formOther | DTL, TVPMState lab |
| Telmisartan Tablets IP 40 mg | Batch 493TTF009Mfg Aug 2025 · Exp Jul 2027 | Swiss Garnier Life SciencesHimachal Pradesh | The sample does not conform to IP standards with respect to the test Dissolution.Dissolution | RDTL, ErnakulamState lab |
| Telmisartan Tablets IP 40 Mg | Batch SPE250642Mfg May 2025 · Exp Apr 2027 | Aristo Pharmaceuticals Pvt. LtdSikkim | The sample does not conform to I.P. w.r.to the tests for Identification and AssayAssay | SDTL, GuwahatiState lab |
| Telmisartan Tablets IP 20mg | Batch PRT2601-29Mfg Jan 2026 · Exp Dec 2027 | Regent Ajanta Biotech 86-87Uttarakhand | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab |
| Telmisartan Tablets IP 20mg | Batch PRT2601-30Mfg Jan 2026 · Exp Dec 2027 | Regent Ajanta Biotech 86-87Uttarakhand | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab |
| Telmisartan Tablets IP | Batch AR250764Mfg Jun 2025 · Exp May 2027 | Alteus Remedies Pvt.LtdJammu & Kashmir | The Dissolution test for Telmisartan tablets does not comples, hence it is Not of Standard Quality.Dissolution | State Lab, DCL, TelanganaState lab |
| Telmisartan & Amlodipine Besylate Tablets IP | Batch PRT2602-149Mfg Feb 2026 · Exp Jan 2028 | Regent Ajanta Biotech 86-87Uttarakhand | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab |
| Telmisartan 40mg & Amlodipine 5mg Tablets IP | Batch BPH252331Mfg Aug 2025 · Exp Jul 2027 | Aristo Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab |
| Telmisartan 40mg & Amlodipine Besylate Tablets IP 5mg | Batch PRT2512-47Mfg Dec 2025 · Exp Nov 2027 | Regent Ajanta BiotechUttarakhand | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab |
| Telmisartan & Amlodipine Tablets IP | Batch 25440443Mfg Jan 2025 · Exp Dec 2026 | Alkem Health ScienceSikkim | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab |
| Teicoplanin Injection IP 200mg | Batch LY052509BMfg Jul 2025 · Exp Jun 2027 | Protech Telelinks Mauza OgliHimachal Pradesh | The sample does not conform for the test Description of Powders for Injection.Description | MDTL KathuaState lab |
| Surgical Spirit IP | Batch SS004Mfg Jun 2023 · Exp Jan 2027 | Medifine Pharma LabKarnataka | Weight per ml, Identification test A and Assay for Methyl Salicylate and Diethyl PhthalateAssay | DTL, Bengaluru, KarnatakaState lab |
| Sucralfate & Oxetacaine Suspension | Batch SCI-2508Mfg Dec 2025 · Exp Nov 2027 | Apple Formulations Pvt. LtdUttarakhand | ContentOther | DTL, Madurai-19State lab |
| Simethicone Drops 30ml | Batch EH25057Mfg Nov 2025 · Exp Oct 2028 | Priya Life ScienceGujarat | The sample does not conform to Manufacturers specification with respect to test for pH and Assay.Assay | CDTL, MumbaiCDSCO lab |
| Shubham Kumkum | Batch SE002Mfg Oct 2025 · Exp Mar 2027 | Shubham Enterprises | The sample does not comply with specification for kumkum powder for the test of pH. And fineness residue on 75 micron sieve, for test of pH and fineness 1. pH. 2.94 (Limit5.5 to 9.0 2. Fineness on 75 Micron sieve 19.37% by mass (IS limit max 1.5% by masspH | FDAL, MumbaiState lab |
| Serratiopeptidase Tablets I P 10 mg | Batch MT260002Mfg Jan 2026 · Exp Dec 2027 | Mancare Laboratories Pvt. LtdUttarakhand | It fails the test Disintegration as per IPDisintegration | RDTL ErnakulamState lab |
| STERI FINE HAND SANITIZER | Batch PS006Mfg Jun 2025 · Exp May 2027 | Kalpa Industries | Identification and Assay for EthanolAssay | DTL, Bengaluru, KarnatakaState lab |
| Ranitidine Oral Solution IP | Batch RAN191Mfg Jul 2025 · Exp Jun 2027 | Revive Formulation India PvtTamil Nadu | ContentOther | DTL, Madurai-19State lab |
| Ranitidine Oral Solution IP | Batch L5E068Mfg May 2025 · Exp Apr 2027 | Samyan Health Care Pvt. LtdHimachal Pradesh | Sample does not conform to IP standards with respect to AssayAssay | DTL, ThrissurState lab |
| Ranitidine HCL I.P. 150 mg). | Batch 25S007B01Mfg Oct 2025 · Exp Sep 2027 | Daundi Biological Pvt. LtdUttarakhand | Storage - Does not comply with I.P.Other | SDFTL US Nagar,UKState lab |
| Rabeprazole Sodium Tablet IP | Batch ATG5H619Mfg Aug 2025 · Exp Jul 2027 | Anrose pharma 147Himachal Pradesh | Test For Assay (Content) Of Rabeprazole SodiumAssay | DelhiState lab |
| Rabeprazole Gastro resistant Tablets IP 20 m | Batch UA01493Mfg Jun 2024 · Exp May 2026 | LUPIN LtdSikkim | Dissolution test (Buffer stage)Dissolution | SDT&RL, BhubaneswarState lab |
| Promethazine Hydrochloride Syrup IP | Batch MDL-C819Mfg Dec 2025 · Exp Nov 2027 | Marvellon Pharmaceuticals Pvt. LtdHimachal Pradesh | ContentOther | DTL, Chennai-06State lab |
| Povidone-Iodine Ointment USP 5% w/w | Batch EP25081ALMfg Oct 2025 · Exp Sep 2027 | Hindustan Laboratories LimitedMaharashtra | The sample does not conform to claim as per USP 2025 in respect to the Assay of Povidone-Iodine as Available IodineAssay | RDTL, ChandigarhCDSCO lab |
| Povidone-Iodine & Metronidazole Ointment | Batch 25343AMfg Aug 2025 · Exp Jul 2027 | Athens Life SciencesHimachal Pradesh | ContentOther | DTL, Madurai-19State lab |
| Povidone- Iodine Solution IP 5% | Batch PI-61Mfg Sep 2025 · Exp Aug 2027 | Vinayak Manutrade (P) LtdRajasthan | The sample does not conform to the IP with respect to Description, Identification pH and Assay (Nil)Assay | DTL JaipurState lab |
| Phenytoin Sodium Injection USP 2ml | Batch 33P25002Mfg Sep 2025 · Exp Aug 2027 | Radiant Parenterals LtdGujarat | The sample does not conform to U.S.P. 48 with respect to the Test for Alcohol and Propylene Glycol content (Alcohol content)Other | CDTL, MumbaiCDSCO lab |
| Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup IP | Batch KKP-006Mfg Feb 2025 · Exp Jan 2027 | Park PharmaceuticalsHimachal Pradesh | ContentOther | DTL, Madurai-19State lab |
| Phenazone & Lidocaine Hydrochloride Ear Drops -5ml | Batch AOT01ACBMfg Jan 2026 · Exp Dec 2027 | Pure & Cure Healthcare Pvt. LtdUttarakhand | ContentOther | DTL, Chennai-25State lab |
| Permethrin, Cetrimide, Aloe vera & Eucalyptus oil | Batch 25F170Mfg Mar 2025 · Exp Feb 2027 | Fabian Life Sciences Phase ?IGujarat | Assay for Permethrin and Cetrimide only.Assay | RDTL, Hubli, KarnatakaState lab |
| Permethrin Medicated Soap | Batch 9147Mfg Sep 2025 · Exp Aug 2027 | Vimson DermaGujarat | ContentOther | DTL, Chennai-06State lab |
| Paracetamol Tablets IP 500mg | Batch PAK-752Mfg Jul 2024 · Exp Jun 2027 | Healer's Lab Unit IIHimachal Pradesh | The sample does not conform to IP standards. It fails the test Dissolution and Description' mentioned in the laboratory protocol as per IPDissolution | DTL, KonniState lab |
| Paracetamol Tablets IP 500mg | Batch PAK-619Mfg Jan 2024 · Exp Dec 2026 | Healer's Lab Unit IIHimachal Pradesh | The sample does not conform to IP standards. It fails the test Dissolution and Description mentioned in the laboratory protocol as per IPDissolution | DTL, KonniState lab |
| Paracetamol Tablets IP 500 mg | Batch AMJ0711Mfg Dec 2023 · Exp Nov 2026 | Acme Formulations Pvt LtdHimachal Pradesh | DissolutionDissolution | DTL, TVPMState lab |
| Paracetamol Tablets IP 500 mg | Batch PAK-643Mfg Feb 2024 · Exp Jan 2027 | Healer's Lab Unit IIHimachal Pradesh | Sample does not conform to IP 2022 standards. This particular batch sample fails the test DissolutionDissolution | RDTL, ErnakulamState lab |
| Paracetamol Tablets IP 500 mg | Batch PAK-628Mfg Jan 2024 · Exp Dec 2026 | Healer's Lab Unit IIHimachal Pradesh | It fails the test Dissolution as per IP as specified in the Laboratory Protocol.Dissolution | DTL, TVPMState lab |
| Paracetamol Tablets IP 500 mg | Batch PAK-557Mfg Sep 2023 · Exp Aug 2026 | Healer's Lab Unit IIHimachal Pradesh | The sample does not conform to IP standards. It fails the test Dissolution.Dissolution | DTL, KonniState lab |
| Paracetamol Tablets I.P 650 mg | Batch PCT25058Mfg Apr 2025 · Exp Mar 2027 | Vivek Pharmachem (India) LtdRajasthan | Test for DissolutionDissolution | RDTL, Hubli, KarnatakaState lab |
| Paracetamol Paediatric Oral suspension IP | Batch L5DD15Mfg Jan 2025 · Exp Dec 2026 | Zenith Drugs Ltd. 72/5 & 72/3Madhya Pradesh | The sample does not comply with IP requirement for related substances test. The sample does notshow identification test for colour carmoisine, Hence the sample is misbranded vide rule 96 and section 17(b) and 17 (c) of Drugs and Cosmetics Act 1940 and Rules thereunderIdentification | FDAL, MumbaiState lab |
| Paracetamol Paediatric Oral suspension IP | Batch LB5172Mfg Oct 2025 · Exp Sep 2027 | Zenith Drugs Ltd. 72/5 & 72/3Madhya Pradesh | The sample does not comply with IP requirement for related substances.Related substances | FDAL, MumbaiState lab |
| Paracetamol Paediatric Oral Suspension IP 250mg, 60ml | Batch SL25156Mfg Mar 2026 · Exp Feb 2028 | Skylink PharmaGujarat | The sample does not conform to as per I.P. 2022 with respect to the test of Microbial contamination (Total aerobic viable count).Microbial limits | CDTL, MumbaiCDSCO lab |
| Paracetamol Paediatric Oral Suspension IP | Batch L5G174Mfg Jul 2025 · Exp Jun 2027 | Smayan Healthcare Pvt. LtdHimachal Pradesh | Test For Assay (Content) Of ParacetamolAssay | DelhiState lab |
| Paracetamol Paediatric Oral Suspension IP | Batch L5G175Mfg Jul 2025 · Exp Jun 2027 | Smayan Healthcare Pvt. LtdHimachal Pradesh | Test For Assay (Content) Of ParacetamolAssay | DelhiState lab |
| Paracetamol Oral Suspension IP | Batch 25K-3031Mfg Nov 2025 · Exp Oct 2027 | Varav Biogenesis Pvt.LtdHimachal Pradesh | ContentOther | DTL, Chennai-06State lab |
| Paracetamol Infusion IP 10 mg/ml | Batch DI115132Mfg Nov 2025 · Exp Oct 2027 | Ultra Laboratories Pvt. LtdKarnataka | Description onlyDescription | DTL, Bengaluru, KarnatakaState lab |
| Paracetamo l Tablets IP 650 mg | Batch CMHP26001Mfg Jan 2026 · Exp Dec 2028 | Curetech Formulations Pvt. LtdHimachal Pradesh | Dissolution TestDissolution | SDTL,Andhra Pradesh, VijayawadaState lab |
| Pantoprazole Gastro-resistant Tablets IP | Batch TG25-03290Mfg Feb 2025 · Exp Jan 2027 | Athens Life SciencesHimachal Pradesh | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution in Acid Stage for Pantoprazole and Description.Dissolution | RDTL, GuwahatiCDSCO lab |
| Pantoprazole Gastro-Resistant Tablets IP 40 mg | Batch MMPT9348Mfg Jan 2026 · Exp Dec 2027 | Middle Mist Pharmaceuticals PvtTamil Nadu | ContentOther | DTL, Madurai-19State lab |
| Pantoprazole Gastro Resistant Tablets IP 40 mg | Batch ZTC-165Mfg Mar 2025 · Exp Feb 2027 | Zoic Biotech Pvt .LtdPunjab | The sample does not conform to the IP standards with respect to the test for DissolutionDissolution | DTL, ThrissurState lab |
| Pantoprazole Gastro Resistant Tablets IP 40mg | Batch T-3423Mfg Nov 2024 · Exp Oct 2026 | Jackson Laboratories Pvt. LtdPunjab | Does not conform to IP Standards with respect to Description and Dissolution TestDissolution | FDL, Bambolim GoaState lab |
| Pantoprazole Gastro Resistant Tablets IP 40mg | Batch SPG240936Mfg Jul 2024 · Exp Dec 2026 | Aristo Pharmaceuticals Pvt. LtdSikkim | The sample does not conform to I.P. w.r.to the tests for Identification AssayAssay | SDTL, GuwahatiState lab |
| Oral Rehydration Salts IP | Batch 4047Mfg Mar 2026 · Exp Feb 2028 | Super Formulations Pvt. Ltd | Net WeightWeight | SDTL, PunjabState lab |
| Oral Rehydration Salts IP | Batch 4043Mfg Mar 2026 · Exp Feb 2028 | Super Formulations Pvt. Ltd | Net WeightWeight | SDTL, PunjabState lab |
| Ofloxacin Tablets IP | Batch SPA252289Mfg Oct 2025 · Exp Sep 2028 | Skymap Pharmaceuticals Pvt. LtdUttarakhand | Failed Dissolution testDissolution | DTL, PuducherryState lab |
| Ofloxacin And Ornidazole Tablet IP | Batch GT301348Mfg Dec 2025 · Exp Nov 2026 | Gnosis Pharmaceuticals Pvt. LtdHimachal Pradesh | DescriptionDescription | RDTL, Bellary, KarnatakaState lab |
| Ofloxacin & Ornidazole Tablets IP | Batch SHT-26877Mfg Aug 2025 · Exp Jul 2027 | Sunvet HealthcareHimachal Pradesh | Test for Dissolution for Ofloxacin & OrnidazoleDissolution | RDTL, Bellary, KarnatakaState lab |
| ORAL REHYDRATION SALTS IP | Batch 4033Mfg Mar 2026 · Exp Mar 2028 | Super Formulations Pvt. Ltd | Average Net Contents per sachet found to be 20.3532gm against claim of 20.5gm per sachetOther | SDTL, PunjabState lab |
| Noscapine, Sodium Citrate, Ammonium Chloride Oral Suspension | Batch D3801625Mfg Mar 2025 · Exp Aug 2027 | Biological E. LimitedUttarakhand | The sample does not conform to Manufacturer's specification with respect to Assay of Noscapine.Assay | CDL KolkataCDSCO lab |
| Nexicold Total | Batch AMT-1925Mfg Jul 2025 · Exp Jun 2027 | Avalon Medicines Pvt. LtdHaryana | The sample does not conform to the tests Description and Disintegration of Tablets. Also, the colour is not mentioned on the label which is violation of Rule 127(2) of Drug Rules, 1945.Description | MDTL KathuaState lab |
| Neeta Mehandi Cone | Batch A09NMfg Jan 2026 · Exp Dec 2026 | Yutika Natural Pvt. LtdRajasthan | The sample of cosmetics ? (C) Does not conform to the claims made on the label as to the nature and quality of the cosmetic with respect to Microbial Contamination.Microbial limits | DTL JaipurState lab |
| Neeta Mehandi Cone | Batch A12NMfg Jan 2026 · Exp Dec 2026 | Yutika Natural Pvt. LtdRajasthan | The sample of cosmetics ? (C) Does not conform to the claims made on the label as to the nature and quality of the cosmetic with respect to Microbial Contamination.Microbial limits | DTL JaipurState lab |
| Montelukast, Levocetrizine Dihydrochloride | Batch ALL1169Mfg Aug 2024 · Exp Jul 2026 | Arcon LabsHimachal Pradesh | Content of MontelukastOther | SDT&RL, BhubaneswarState lab |
| Montelukast Tablets I.P. | Batch CRT-250217Mfg Feb 2025 · Exp Jan 2027 | Civron PharmaceuticalsHimachal Pradesh | The sample is found to be Not of Standard Quality for the reason stated under Description.Description | CDL KolkataCDSCO lab |
| Milk of Magnesia, Liquid Paraffin & Sodium Picosulfate | Batch HL24152Mfg Nov 2024 · Exp Oct 2026 | Healtech BiosciencesHimachal Pradesh | Description onlyDescription | RDTL, Hubli, KarnatakaState lab |
| Methylcobalamin Oral Disintegrating Tablets 1500 mcg | Batch MOD10205DMfg Dec 2025 · Exp Nov 2027 | Pulse Pharmaceuticals Pvt. LtdUttarakhand | DescriptionDescription | SDTL, PunjabState lab |
| Methotrexate Tablets IP 2.5mg | Batch SPOT260026BMfg Feb 2026 · Exp Jan 2028 | Salus Pharmaceuticals | MisbrandedMisbranded | Andmand NicobarState lab |
| Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP (500mg/2mg) | Batch PRT-250229Mfg Feb 2025 · Exp Jan 2027 | Preet Remedies LtdHimachal Pradesh | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Mefenamic Acid and Paracetamol Tablets | Batch T3209Mfg May 2024 · Exp Apr 2027 | Jersy Pharma | Sample does not conform to Schedule V of the Drugs Rules, 1945 with respect to the Assay of Mefenamic Acid as specified in the laboratory protocol.Assay | RDTL ErnakulamState lab |
| Mefenamic Acid Tablets B.P. 500 mg, | Batch T-2506151Mfg Jun 2025 · Exp May 2027 | Aagya Biotech Pvt. LtdUttarakhand | The Sample does not confirms to BP standards with respect to the test DisintegrationDisintegration | RDTL ErnakulamState lab |
| Magnesium Sulphate Injection I.P-2ml | Batch 201Mfg Jan 2026 · Exp Dec 2027 | Hindustan Medicines Pvt. Ltd | pHpH | DTL, Chennai-06State lab |
| Lorazepam Tablets IP 1mg | Batch NTE0461Mfg Jul 2024 · Exp Jun 2026 | Digital VisionHimachal Pradesh | Assay and DissolutionAssay | SDT&RL, BhubaneswarState lab |
| Loperamide Hydrochloride Tablets IP 2mg | Batch 2402Mfg Mar 2025 · Exp Feb 2027 | Abil Healthcare 311Madhya Pradesh | Failed AssayAssay | DTL, PuducherryState lab |
| Levosalbutamol Sulphate, Ambroxol HCl & Guaiphenesin Syrup 60 ml | Batch SD-1376CMfg Jul 2025 · Exp Jun 2027 | Sano-Cito Therapeutics IncHimachal Pradesh | The sample does not conform to claim as per Schedule V of Drugs and Cosmetic Acts and Rules 1945 with respect to Assay/content of Levosalbutamol sulphate Equivalent to Levosalbutamol.Assay | CDL KolkataCDSCO lab |
| Levosalbutamol Sulphate Ambroxol Hydrochloride and Guaiphenesin Expectorant. | Batch 18253692AMfg Sep 2025 · Exp Aug 2027 | Macleods Pharmaceuticals LtdSikkim | Description as per Schedule V of Drugs and Cosmetics act 1940 & Rules 1945 thereunder.Description | DTL, Bengaluru, KarnatakaState lab |
| Levocetirizine HCl & Montelukast Sodium Syrup. | Batch SL-151Mfg Jun 2025 · Exp May 2027 | Shivam Enterprises (Pharma Division)Himachal Pradesh | Assay Of Montelukast Sodium I.P. ? Less than prescribed limit.Assay | SDFTL US Nagar,UKState lab |
| Levocetirizine Dihydrochloride Tablets IP 5mg | Batch PRT2501-149Mfg Jan 2025 · Exp Dec 2026 | Regent Ajanta BiotechUttarakhand | The sample does not conform to standard quality in respect of the test for Description performed.Description | SDTL, Tripura, AgartalaState lab |
| Levetiracetam Tablets IP 1000mg | Batch ADT251795Mfg Jun 2025 · Exp May 2027 | Astonea Labs Pvt. LtdHaryana | The sample is found Not of Standard Quality for the reason stated under Description as per Schedule V of Drugs and Cosmetic Acts and Rules.Description | CDL KolkataCDSCO lab |
| Lenvatinib Capsules IP 4 mg | Batch ACC2502LVMfg May 2025 · Exp Apr 2027 | Aprazer Healthcare Pvt. LtdHimachal Pradesh | The sample does not conform toI.P. with respect to the test for Identification Lenvatinib mesylate eq. to Lenvatinib.Identification | CDL KolkataCDSCO lab |
| Kumkum Pinjar | Batch 06Mfg Feb 2026 · Exp Jan 2028 | M.V. Vaze Consumer Products House No. 107/3 | The sample does not comply with specification for kumkum powder for the test of pH. pH. 2.70 is limit 5.5 to 9.0pH | FDAL, MumbaiState lab |
| Ketoconazole & Chlorhexidine Gluconate Lotion | Batch 129Mfg Sep 2025 · Exp Feb 2027 | Argion Cosmed India Pvt. LtdTamil Nadu | ContentOther | DTL, Chennai-06State lab |
| Itraconazole Capsule IP 200 mg | Batch IG25045Mfg Jun 2025 · Exp May 2027 | Innova Captab LtdHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab |
| Iodine Tincture 2% v/v) | Batch TI-2411Mfg Sep 2024 · Exp Aug 2026 | Cymer PharmaMadhya Pradesh | Alcohol content and Assay for Iodine and Potassium IodideAssay | DTL, Bengaluru, KarnatakaState lab |
| Ibuprofen Tablets IP 400 mg | Batch IBPT-1002Mfg Jul 2024 · Exp Jun 2027 | Wings Biotech LLPHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab |
| Ibuprofen Tablets IP 400 mg | Batch IBK-2503Mfg Jun 2025 · Exp May 2028 | Askon Health Care | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Ibuprofen.Dissolution | RDTL, GuwahatiCDSCO lab |
| Hingwasht Churna | Batch HC09/24Mfg Sep 2024 · Exp Aug 2026 | Inducare Pharma Pvt. Ltd.Factory-C-34Maharashtra | The sample does not comply with API requirement for total Ash(i.e 32%) which is more than the permissible limit2. The sample does not found to contain insects, wabbing, Larvae and any other extraneous matter when observed in normal day light with naked eye.Other | FDAL, MumbaiState lab |
| Glimepiride Tablets IP 1mg | Batch M25799027Mfg Oct 2025 · Exp Sep 2027 | Dr.Miltons Laboratories Private LimitedPuducherry | DissolutionDissolution | DTL, Chennai-06State lab |
| Glimepiride Tablets IP 1mg | Batch M25799030Mfg Nov 2025 · Exp Oct 2027 | Dr.Miltons Laboratories Private LimitedPuducherry | DissolutionDissolution | DTL, Chennai-06State lab |
| Gentamicin Injection IP-40mg/ml-2ml | Batch 683511Mfg Nov 2025 · Exp Oct 2027 | Zazen Pharma Pvt. Ltd | pHpH | DTL, Chennai-06State lab |
| Gentamicin Eye/Ear Drops 5 ml | Batch 1224-226Mfg Jun 2024 · Exp May 2026 | Zee Laboratories LtdHimachal Pradesh | The sample does not conform to Manufacturer's specification with respect to test for Particulate MatterParticulate matter | CDL KolkataCDSCO lab |
| Gamma Benzene Hexachloride Lotion USP | Batch 6P46Mfg Apr 2026 · Exp Mar 2028 | Yacca Lifesciences Pvt LtdUttarakhand | The Cited Product is official in IP Which it is Printed USP an the label of the cited product.Labelling | SDTL, PunjabState lab |
| Gamma Benzene Hexachloride Lotion USP | Batch 6P48Mfg Apr 2026 · Exp Mar 2028 | Yacca Lifesciences Pvt LtdUttarakhand | The Product is official in I.P but is mentioned as USP on the labelLabelling | SDTL, PunjabState lab |
| Gamma Benzene Hexachloride Lotion USP | Batch 6P45Mfg Apr 2026 · Exp Mar 2028 | Yacca Lifesciences Pvt LtdUttarakhand | The Cited Product is official in I.P Which it is Printed USP an the label of the cited product.Labelling | SDTL, PunjabState lab |
| Gamma Benzene Hexachloride Lotion USP | Batch 6P47Mfg Apr 2026 · Exp Mar 2028 | Yacca Lifesciences Pvt LtdUttarakhand | The Cited Product is official in I.P Which it is Printed as USP on the label of the cited product.Labelling | SDTL, PunjabState lab |
| Gamma Benzene Hexachloride Lotion USP | Batch H-516Mfg Sep 2025 · Exp Aug 2027 | Cotec Healthcare Pvt. LtdUttarakhand | ContentOther | DTL, Chennai-06State lab |
| Furosemide & Spironolactone Tablets | Batch CT24251187BMfg Oct 2024 · Exp Sep 2026 | CMG Biotech Pvt. Ltd | Description as per Schedule V of Drugs and Cosmetics act 1940 & Rules 1945 thereunder.Description | DTL, Bengaluru, KarnatakaState lab |
| Fungal Diastase (Estimated in terms of amylase activity) Pepsin (Estimated in terms ofvolume of undissolved egg albumin) | Batch SR-14Mfg May 2025 · Exp Apr 2027 | Sresan Pharmaceutical Manufacturer No. 787. Bangalore HighwaysKarnataka | Alpha amylase activity and Pepsin contentOther | SDT&RL, BhubaneswarState lab |
| Fungal Diastase (Estimated in terms of amylase activity) Pepsin (Estimated in terms ofvolume of undissolved egg albumin) | Batch 380725-UNMfg Jul 2025 · Exp Dec 2026 | Biogenetic Drugs Ptv. LtdHimachal Pradesh | Content of PepsinOther | SDT&RL, BhubaneswarState lab |
| Formaldehyde IP Solution | Batch FD4686Mfg Sep 2023 · Exp Aug 2026 | Krishna Pharma C-18/5/ATelangana | The Sample does not comply test parameter description as it contains white crystals. 2. Label states Formaldehyde I.P solution which is not availabe in current edition of IP.Description | State Lab, DCL, TelanganaState lab |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE063Mfg Nov 2024 · Exp Oct 2027 | Unicure India LtdUttarakhand | Sample does not conform to IP standards. It fails the tests Dissolution and Assay as per IP.Assay | DTL, KonniState lab |
| Fluorometholone Eye Drops IP, Flomia Eyedrops | Batch HE5106AMfg Apr 2025 · Exp Mar 2027 | Hanuchem LaboratoriesHimachal Pradesh | The sample does not conform to IP standards. This particular batch of sample fails the tests Sterility and AssayAssay | RDTL, ErnakulamState lab |
| Ferrous Sulphate And Folic Acid Tablets I.P. | Batch CFR-Y15Mfg Apr 2025 · Exp Mar 2027 | Cyano Pharma (P) LtdMadhya Pradesh | DescriptionDescription | RDTL, Hubli, KarnatakaState lab |
| Ferrous Sulphate & Folic Acid Tablets I.P. | Batch B250205Mfg Feb 2025 · Exp Jan 2027 | Bochem Healthcare Pvt. Ltd | Description Tablets having Mottling Defect/Discoloration.Description | SDFTL US Nagar,UKState lab |
| Ferrous Asparto Glycinate L- Methylfolate Calcium & Methylcobalamin Soft Gelatin Capsules | Batch D251058AMfg Apr 2025 · Exp Mar 2027 | Sigma Softgel & FormulationHimachal Pradesh | Sample does not confrom to Schedule V of the Drug Rule 1945 with respect to the disintegration and assay of L-Methylfolate Calcium as specified in the laboratory protocol.Assay | RDTL, ErnakulamState lab |
| Etodolac Tablets IP | Batch PNT5-1754AMfg Mar 2026 · Exp Feb 2028 | Pacific IndiaHimachal Pradesh | The sample received does not conform to i.p.2022 specification with respect to the test for DissolutionDissolution | CDTL-HyderabadCDSCO lab |
| Esomeprazole Tablets IP | Batch ZRST-3430Mfg Feb 2026 · Exp Jan 2028 | ZRS Pharmaceuticals India Pvt. LtdHimachal Pradesh | Sample does not conform to IP Standards. If fails the tests Assay and Dissolution as per IPAssay | DTL, TVMState lab |
| Esomeprazole Magnesium Tablets IP 40mg | Batch VGT250168Mfg Sep 2025 · Exp Aug 2028 | Vapi Care Pharma Pvt. LtdGujarat | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the test of Dissolution (Buffer Stage).Dissolution | RDTL, ChandigarhCDSCO lab |
| Escitalopram Oxalate & Clonazepam Tablets IP | Batch NT250199Mfg Sep 2025 · Exp Aug 2027 | Oxford PharmaUttarakhand | The sample does not conform to the I.P. with respect to test for Related Substance and Description.Description | CDL KolkataCDSCO lab |
| Enteric Coated Rabeprazole Sodium & Domperidone Sustained Release Capsules | Batch RDAA24009Mfg Oct 2024 · Exp Sep 2026 | Signova Healthcare Pvt. Ltd (Unit-II)Assam | The sample does not conform to I.P. w.r.to the tests for Dissolution & AssayAssay | SDTL, GuwahatiState lab |
| Enteric Coated Rabeprazole Sodium & Domperidone (SR) Capsules | Batch VDR24002Mfg Sep 2024 · Exp Aug 2026 | Windlas Biotech Limited Plain-2Uttarakhand | Uniformity of WeightUniformity of weight/content | SDTL, PunjabState lab |
| Drotaverine Hydrochloride & Mefenamic Acid Tablets | Batch DMR-504Mfg Jan 2026 · Exp Dec 2027 | Healer's Lab Unit IIHimachal Pradesh | The sample does not conforms to the claim with respect to description as it show physical instability in the form of Mottling.Description | DTL, UdaipurState lab |
| Disposable Syringe For Single Use Only | Batch 052502GX01Mfg May 2025 · Exp Apr 2028 | Sterisafe Health Solutions | The sample does not comply as per IP 2022 with respect to the test for Sterility.Sterility | RDTL, GuwahatiCDSCO lab |
| Dicyclomine Tablets IP 10 mg | Batch THY25005ALMfg Apr 2025 · Exp Mar 2028 | Hindustan Laboratories LimitedMaharashtra | Sample does not conform to IP standards with respect to Description.Description | RDTL ErnakulamState lab |
| Diclofenac Sodium Tabelts IP 50 mg | Batch DG5034Mfg Mar 2025 · Exp Feb 2027 | Kerala State Drugs and Pharmaceuticals LtdKerala | The sample does not conform to IP standards. If fails the Descriptive part as per IP,as specified in the Laboratory Protocol.Other | DTL TVPMState lab |
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup | Batch OML24074Mfg Dec 2024 · Exp Nov 2026 | Omish Laboratories Pvt. LtdGujarat | Phenylephrine Hydrochloride ContentOther | FDL, VadodaraState lab |
| Dextromethorphan Hydrobromide, Phenylephrine Hcl, Chlorpheniramine Maleate Syrup | Batch VDGS-483Mfg Sep 2025 · Exp Aug 2027 | Vzoic Healthcare Pvt. LtdPunjab | ContentOther | DTL, Madurai-19State lab |
| Dextromethorphan Hydrobromide, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Syrup | Batch S-199/25Mfg Jul 2025 · Exp Jun 2027 | Aban PharmaceuticalsKerala | Dextromethorphan Hydrobromide contentOther | FDL, VadodaraState lab |
| Deflazacort Tablets 6 mg | Batch GT25943Mfg Sep 2025 · Exp Aug 2027 | Devbhoomi PharmaceuticalsUttarakhand | Assay for DeflazacortAssay | RDTL, Bellary, KarnatakaState lab |
| Deferasirox Dispersible Tablets 100mg | Batch DFA03G25Mfg Jul 2025 · Exp Jun 2027 | Bajaj Healthcare LtdGujarat | The sample is declared to be not of standard quality for the reason stated under Description and as it does not conform to Manufacturer's Specification with respect to the tests of Hardness and Friability.Description | CDL KolkataCDSCO lab |
| Cyproheptadine Hydrochloride & Tricholine Citrate Syrup | Batch ZL-021Mfg Dec 2025 · Exp Nov 2027 | Glorius PharmaceuticalsBihar | The sample does not conform to claim with respect to the test for Assay of Cyproheptadine Hydrochloride and Tricholine Citrate, and Description.Assay | CDL KolkataCDSCO lab |
| Cyproheptadine HCL & Tricholine Citrate Syrup | Batch CL25122Mfg Aug 2025 · Exp Jul 2027 | Clever Formulations | Microbial Contamination: Total Aerobic Viable Count (TAC)Microbial limits | FDL, VadodaraState lab |
| Compound Sodium Lactate Injection (Ringer Lactate Solution for IP) 500 ml | Batch OMF241105Mfg Nov 2024 · Exp Oct 2026 | Haseeb Pharmaceuticala Pvt. LtdMaharashtra | The Sample does not conform to claim as per IP 2022 in respect to the pH Particulate Matter,Bacterial Endotoxins & SterilitySterility | DTL, BaddiState lab |
| Co-Trimoxazole Oral Suspension IP | Batch L25/0106AMfg May 2025 · Exp Apr 2027 | Samkem | Content of Trimethoprim In the Sample Is Less (I.E 60.52% Of The Labelled Amount) than the IP limits.Labelling | FDAL, MumbaiState lab |
| Closantel& Ivermectin Oral Liquid Vet | Batch NAP-25068Mfg Nov 2025 · Exp Oct 2027 | Nuvista Pharmaceuticals Pvt.LtdTelangana | Identificatio n and Assay of IvermectinAssay | SDTL,Andhra Pradesh, VijayawadaState lab |
| Clobetasol Propionate, Neomycin, Miconazole Nitrate & Chlorhexidine Cream | Batch DLPS5108Mfg Nov 2025 · Exp Oct 2027 | Leeford Healthcare LtdHimachal Pradesh | ContentOther | DTL, Chennai-06State lab |
| Clobetasol Propionate and Salicylic Acid Ointment | Batch J014Mfg Oct 2025 · Exp Sep 2028 | Karlin Pharmaceuticlas & Exports Private LimitedTamil Nadu | ContentOther | DTL, Madurai-19State lab |
| Ciprofloxacin Tablets IP 500mg | Batch CPT25066Mfg Jun 2025 · Exp May 2028 | Vivek Pharmachem (India) LtdRajasthan | The sample does not conform to IP, in Respect of Dissolution.Dissolution | DTL LucknowState lab |
| Ciprofloxacin HCl Tablets I.P | Batch CXHDT5006Mfg Apr 2025 · Exp Mar 2028 | Laborate Pharmaceuticals India Ltd. IIIHimachal Pradesh | Description Rough surface on each Tablets.Description | SDFTL US Nagar,UKState lab |
| Cilnidipine Tablets IP 10 mg, | Batch GTV26001Mfg Jan 2026 · Exp Dec 2027 | VTV Formulations India Pvt LtdUttarakhand | Sample does not conform to IP 2022 standards. This particular batch sample fails the test DissolutionDissolution | RDTL, ErnakulamState lab |
| Cilnidipine Tablets IP 10 mg | Batch MT261003Mfg Apr 2026 · Exp Mar 2028 | Mascot Health Series Pvt. LtdUttarakhand | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab |
| Chlorhexidine Gluconate Solution IP | Batch HEL-2433Mfg Sep 2024 · Exp Aug 2026 | Texas Lifesciences Pvt. Ltd | Assay for Chlorhexidine GluconateAssay | DTL, Bengaluru, KarnatakaState lab |
| Cetirizine Syrup IP | Batch CIZ-2604Mfg Mar 2026 · Exp Feb 2028 | Apple Formulations Pvt. LtdUttarakhand | pHpH | SDTL, PunjabState lab |
| Cefpodoxime Proxetil Tablets IP 200mg, | Batch LBCC2601Mfg Jun 2026 · Exp Feb 2028 | Linux Life Sciences Pvt.LtdPunjab | The Sample does not meets the Specifications wrt.Description and Dissolution Test as per IP.Dissolution | State Lab, DCL, TelanganaState lab |
| Cefixime Dispersible Tablet IP | Batch VT240492Mfg May 2024 · Exp Apr 2026 | VADSP PharmaceuticalsHimachal Pradesh | The sample does not conform to the IP with respect to Assay of Cefixime Trihydrate eq. to Anhydrous Cefixime.Assay | DTL BikanerState lab |
| Carbimazole Tablets IP | Batch 2510306Mfg Oct 2025 · Exp Sep 2027 | Biodeal Pharmaceuticals Pvt. LtdHimachal Pradesh | ContentOther | DTL, Madurai-19State lab |
| Calcium & Vitamin D3 Tablets IP | Batch T-250024Mfg Apr 2025 · Exp Mar 2027 | Sunlife SciencesUttarakhand | The sample does not conform to claim as per I.P. 2022 with respect to the test for Assay of Vitamin D3.Assay | RDTL, GuwahatiCDSCO lab |
| Bromhexine Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup | Batch L-2601029Mfg Jan 2026 · Exp Dec 2027 | Rivpra Formulation Pvt. LtdUttarakhand | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Bromhexine Hydrochloride.Assay | RDTL, ChandigarhCDSCO lab |
| Bisacodyl gastro-resistant Tablets IP | Batch 2518853T002Mfg Jun 2025 · Exp May 2028 | Scott-Edil Pharmacia LtdHimachal Pradesh | Sample does not conform to IP 2022 standards. This particular batch sample fails the test DissolutionDissolution | RDTL, ErnakulamState lab |
| BENZYL BENZOATEE APPLICATION IP | Batch 3172Mfg Dec 2025 · Exp Nov 2027 | Karnani pharmaceuticals Pvt ltdUttarakhand | The sample does not conform to claim as per IP 2022 in respect to the Assay of Benzyl NenzoateAssay | DRUG TESTING LABORATORY BADDIState lab |
| B-Complex with L-Lysine & Zinc Syrup | Batch BL-2650Mfg Dec 2024 · Exp May 2026 | Bioland PharmaHaryana | The sample does not conform to claim as per Schedule V of Drugs and Cosmetics Act and Rules 1945 with respect to Assay of Zinc, Vitamin B3, Vitamin B1, Vitamin B2, Vitamin B6 and Vitamin D3.Assay | CDL KolkataCDSCO lab |
| AzithromycinTablets IP | Batch 25I-T1749Mfg Dec 2025 · Exp Nov 2027 | Orison Pharma International Khari | Test for Uniformity of Weight of TabletsUniformity of weight/content | RDTL, Bellary, KarnatakaState lab |
| Azithromycin Oral Suspension IP | Batch 26150Mfg Mar 2026 · Exp Feb 2028 | Zeta Formulation Private Limited | pH and ContentpH | DTL, Chennai-06State lab |
| Azithromycin Oral Suspension | Batch AZ/L/01/5005Mfg Oct 2025 · Exp Sep 2027 | Vital Therapeutics & Formulations Pvt.LtdTelangana | Assay for Azithromycin AnhydrousAssay | RDTL, Bellary, KarnatakaState lab |
| Azithromycin Oral Suspension IP 100 mg/5ml | Batch 1501/25Mfg Aug 2024 · Exp Jul 2026 | Livin FormulationsTelangana | Content of AzithromycinOther | SDT&RL, BhubaneswarState lab |
| Atorvastatin Tablets IP 20mg | Batch 0062Mfg Jul 2025 · Exp Jun 2027 | Hindustan Antibiotics LtdMaharashtra | The sample does not conform to claim as per IP 2022 in respect to test of Related substances.Related substances | RDTL, ChandigarhCDSCO lab |
| Atorvastatin Tablets IP 10mg | Batch AC25002Mfg May 2025 · Exp Apr 2027 | Eurokem Laboratories Pvt ltdTamil Nadu | The Sample does not meets the Specifications wrt. Dissolution Test as per IP.Dissolution | State Lab, DCL, TelanganaState lab |
| Amoxycillin& Potassium Clavulanate Tablets IP | Batch MFK0983Mfg Dec 2024 · Exp Nov 2026 | Medicef PharmaHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for Identification and AssayAssay | SDTL, GuwahatiState lab |
| Amoxycillin Oral Suspension IP | Batch PDB108AMfg Nov 2024 · Exp Oct 2026 | Aan Life science Private LimitedGujarat | Content of Amoxycillin.Other | FDL, VadodaraState lab |
| Amoxycillin Oral Suspension IP | Batch PDB110AMfg Nov 2024 · Exp Oct 2026 | Aan Life science Private LimitedGujarat | Content of Amoxycillin.Other | FDL, VadodaraState lab |
| Amoxycillin Oral Suspension IP | Batch PDB121AMfg Nov 2024 · Exp Oct 2026 | Aan Life science Private LimitedGujarat | Content of Amoxycillin.Other | FDL, VadodaraState lab |
| Amoxycillin Oral Suspension IP | Batch PDB117AMfg Nov 2024 · Exp Oct 2026 | Aan Life science Private LimitedGujarat | Content of Amoxycillin.Other | FDL, VadodaraState lab |
| Amoxycillin Oral Suspension IP | Batch PDB098AMfg Nov 2024 · Exp Oct 2026 | Aan Life science Private LimitedGujarat | Content of Amoxycillin.Other | FDL, VadodaraState lab |
| Amoxycillin Oral Suspension IP | Batch PDB099AMfg Nov 2024 · Exp Oct 2026 | Aan Life science Private LimitedGujarat | Content of Amoxycillin.Other | FDL, VadodaraState lab |
| Amoxycillin Oral Suspension IP | Batch PDB119AMfg Nov 2024 · Exp Oct 2026 | Aan Life science Private LimitedGujarat | Content of Amoxycillin.Other | FDL, VadodaraState lab |
| Amoxycillin Oral Suspension IP | Batch PDB111AMfg Nov 2024 · Exp Oct 2026 | Aan Life science Private LimitedGujarat | Content of Amoxycillin.Other | FDL, VadodaraState lab |
| Amoxycillin Oral Suspension IP | Batch PDB114AMfg Nov 2024 · Exp Oct 2026 | Aan Life science Private LimitedGujarat | Content of Amoxycillin.Other | FDL, VadodaraState lab |
| Amoxycillin Oral Suspension IP | Batch PDB105AMfg Nov 2024 · Exp Oct 2026 | Aan Life science Private LimitedGujarat | Content of Amoxycillin.Other | FDL, VadodaraState lab |
| Amoxycillin Oral Suspension IP | Batch PDB107AMfg Nov 2024 · Exp Oct 2026 | Aan Life science Private LimitedGujarat | Content of Amoxycillin.Other | FDL, VadodaraState lab |
| Amoxycillin And Potassium Clavunate Tablets | Batch SPAR25007Mfg Feb 2025 · Exp Jan 2027 | Cosmas Research Lab LtdPunjab | The contents of Clavulanic Acid found to be 107.16mg/Tablet (85.728%) against claim of 125.0mg/Tablet.Other | SDTL, PunjabState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | Batch 25442245Mfg Jun 2025 · Exp Nov 2026 | Alkem Health ScienceSikkim | The sample does not conform to I.P. w.r.to the tests for Identification and AssayAssay | SDTL, GuwahatiState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | Batch VT251451Mfg Sep 2025 · Exp Feb 2027 | VADSP PharmaceuticalsHimachal Pradesh | The Sample does not meets the Specifications wrt. Assay and Dissolution of Clavulanic acid as per IP.Assay | State Lab, DCL, TelanganaState lab |
| Amoxycillin & Potassium Clavulanate Tablets I.P. (Moxkit-CV 625) | Batch MICTAB- 2302Mfg Mar 2025 · Exp Aug 2026 | Micro FormulationsMaharashtra | The sample does not conform to the IP with respect to Assay of Clavulanic Acid (NIL) and Amoxycillin.Assay | DTL JaipurState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP 625 MG, | Batch 825D001Mfg Jan 2025 · Exp Jun 2026 | Medrich LtdKarnataka | The sample does not conform to I.P. w.r.to the tests for Identification and AssayAssay | SDTL, GuwahatiState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | Batch VT251183Mfg Aug 2025 · Exp Jan 2027 | VADSP PharmaceuticalsHimachal Pradesh | Dissolution test and content of Clavulanic AcidDissolution | SDT&RL, BhubaneswarState lab |
| Amlodipine & Atenolol Tablets IP | Batch G65Y010Mfg Jan 2025 · Exp Dec 2026 | Mankind Pharma LtdSikkim | The sample does not conform to I.P. w.r.to the tests for Identification and AssayAssay | SDTL, GuwahatiState lab |
| Amitriptyline Tablets IP 25 mg | Batch GAMT4Mfg Oct 2025 · Exp Sep 2027 | Super Formulations Pvt. Ltd | ContentOther | DTL, Madurai-19State lab |
| Ambroxol Hydrochloride, Terbutaline, Guaiphenesin & Menthol Syrup | Batch KL08501Mfg Mar 2025 · Exp Feb 2027 | Kinesis Laboratories Pvt.LtdHimachal Pradesh | ContentOther | DTL, Chennai-06State lab |
| Ambroxol Hydrochloride Terbutaline Sulphate Guaiphenesin & Menthol Syrup | Batch RG-043Mfg Aug 2025 · Exp Jul 2027 | Redner FormulationsPuducherry | ContentOther | DTL, Madurai-19State lab |
| Albendazole Tablets IP 400mg | Batch UT-969Mfg Sep 2024 · Exp Aug 2026 | Clevus Lifesciences Near Apple Terminal Market | Test for Dissolution onlyDissolution | RDTL, Hubli, KarnatakaState lab |
| Albendazole Tablets IP 400 mg | Batch MT250979Mfg Oct 2025 · Exp Sep 2027 | Mancare Laboratories Pvt. LtdUttarakhand | The sample does not conform to IP with respect to test for Dissolution and Assay of AlbendazoleAssay | CDL KolkataCDSCO lab |
| Adenosine Injection IP 6 mg/2ml | Batch I5K048Mfg Nov 2025 · Exp Oct 2027 | Smayan Healthcare Pvt. LtdHimachal Pradesh | The sample does not conforms to I.P. 2022 with respect to the test for pHpH | CDTL, MumbaiCDSCO lab |
| Adenosine Injection IP 6 mg/2ml | Batch WADG25002AMfg Oct 2025 · Exp Sep 2027 | Welcure RemediesHimachal Pradesh | The sample is not of standard quality as per I.P. 2022 with respect to the Test for Identification, Particulate matter, Sterility, Bacterial endotoxins, Assay/content of Adenosine and is also not of standard quality for the reasons stated under DescriptionAssay | CDTL, MumbaiCDSCO lab |
| Adenosine Injection IP 6 mg/2ml | Batch WADG25001AMfg Aug 2025 · Exp Jul 2027 | Welcure RemediesHimachal Pradesh | The sample does not conforms to I.P. 2022 with respect to the Test of Identification, Particulate matter, Sterility, Bacterial endotoxins and Assay. The sample is deemed spurious as per D and C Act section 17 (B).Assay | CDTL, MumbaiCDSCO lab |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets | Batch FND0826009AKMfg Feb 2026 · Exp Jul 2028 | Ipca Laboratories LtdUttarakhand | Description Rough surface on each Tablets.Description | SDFTL US Nagar,UKState lab |
| Aceclofenac and Paracetamol | Batch T251109Mfg Nov 2025 · Exp Oct 2027 | Medisky Pharmaceuticals Pvt. Ltd | MisbrandadMisbranded | SDTL,ChhattisgarhState lab |
| Aceclofenac and Paracetamol | Batch ET25246Mfg Dec 2025 · Exp Nov 2028 | Edkem Pharmaceuticals LtdGujarat | MisbrandadMisbranded | SDTL,ChhattisgarhState lab |
| Aceclofenac and Paracetamol | Batch SPT251764AMfg Aug 2025 · Exp Jul 2027 | Salus Pharmaceuticals Als 480/21 Harraipur PO Gaunmajara Tah- Baddi Distt- Solan (H.P.) 173205Himachal Pradesh | MisbrandadMisbranded | SDTL,ChhattisgarhState lab |
| Aceclofenac & Paracetamol Tablets I.P. | Batch 5725004Mfg Mar 2025 · Exp Feb 2028 | Leeford Healthcare LtdHimachal Pradesh | Description Rough surface on each Tablets.Description | SDFTL US Nagar,UKState lab |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Sources
- Regulator
- Regulator
Changelog
- 3 Nov 2026: table generated from the CDSCO NSQ portal export (193 rows). Revised CDSCO lists are diffed on each monthly rebuild.